Clinical, biochemical, and genetic characterization of Lebanese patients with chronic granulomatous disease due to NCF2 pathogenic variants
Clinical Immunology · 2025
DOI: 10.1016/j.clim.2025.110596 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Immunology, 2025. Verfasst von Youmna El-Orfali und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Pathology, Immunology, and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon. Hauptthemen laut MEDLINE: Granulomatous Disease, Chronic, NADPH Oxidases. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 29 Literaturangaben. Gefördert von: American University of Beirut, American University of Beirut Faculty of Medicine.
Abstract (Originalsprache)
Chronic Granulomatous Disease (CGD) is caused by mutations in the NADPH oxidase complex that impair the ability of phagocytes to eliminate injested pathogens. As a result, patients with CGD suffer from recurrent infections and chronic inflammation. We report the clinical, biochemical, and genetic basis of the disease in 17 CGD patients from Lebanon. Whole exome sequencing (WES) identified 2 distinct mutations in NCF2 resulting in the deletion of exons 3 and 5, accounting for 82 % of the cases that underwent WES. This high prevalence provided the rationale for a diagnostic strategy involving assessment of NADPH oxidase function, identification of the affected protein, and targeted gene sequencing. Using this approach, 3 additional CGD patients with simmilar deletions were identified, supporting the presence of a founder effect in the Lebanese population. This biochemical and tageted sequencing approach is rapid, reliable, and cost-effective, making it a particularly valuable diagnostic option for families who cannot afford WES.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Experimental Pathology, Immunology, and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon.
- Division of Pediatric Infectious Diseases, Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Beirut, Lebanon.
- Division of Pediatric Infectious Diseases, Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Beirut, Lebanon; Center for Infectious Diseases Research, American University of…
- Department of Experimental Pathology, Immunology, and Microbiology, Faculty of Medicine, American University of Beirut, Beirut, Lebanon; Division of Pediatric Infectious Diseases, Department of Pediatrics and Adolescent…
Förderung
- American University of Beirut
- American University of Beirut Faculty of Medicine
Zitieren
APA
El-Orfali, Y., Mardirossian, H., Al-Kalamouni, H., El-Zein, Z., Dalle, S., Khreis, D., Haddara, A., Hanna-Wakim, R., Dbaibo, G., & Massaad, M. J. (2025). Clinical, biochemical, and genetic characterization of Lebanese patients with chronic granulomatous disease due to NCF2 pathogenic variants. Clinical Immunology. https://doi.org/10.1016/j.clim.2025.110596
Vancouver
El-Orfali Y, Mardirossian H, Al-Kalamouni H, El-Zein Z, Dalle S, Khreis D, et al. Clinical, biochemical, and genetic characterization of Lebanese patients with chronic granulomatous disease due to NCF2 pathogenic variants. Clinical Immunology. 2025. doi:10.1016/j.clim.2025.110596
BibTeX
@article{ElOrfali2025,
author = {El-Orfali, Youmna and Mardirossian, Hagop and Al-Kalamouni, Habib and El-Zein, Zeinab and Dalle, Samar and Khreis, Dima and Haddara, Amani and Hanna-Wakim, Rima and Dbaibo, Ghassan and Massaad, Michel J},
title = {Clinical, biochemical, and genetic characterization of Lebanese patients with chronic granulomatous disease due to NCF2 pathogenic variants},
journal = {Clinical Immunology},
year = {2025},
doi = {10.1016/j.clim.2025.110596}
}
EUVIMED